Related references
Note: Only part of the references are listed.Characterization of Alpha-Toxin hla Gene Variants, Alpha-Toxin Expression Levels, and Levels of Antibody to Alpha-Toxin in Hemodialysis and Postsurgical Patients with Staphylococcus aureus Bacteremia
Batu K. Sharma-Kuinkel et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Assessment of an Anti-Alpha-Toxin Monoclonal Antibody for Prevention and Treatment of Staphylococcus aureus-Induced Pneumonia
L. Hua et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Developments in skin and soft tissue infection
Matthew S. Dryden
CURRENT OPINION IN INFECTIOUS DISEASES (2014)
Mechanisms of Neutralization of a Human Anti-α-toxin Antibody
Vaheh Oganesyan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Targeting Staphylococcus aureus α-Toxin as a Novel Approach to Reduce Severity of Recurrent Skin and Soft-Tissue Infections
Georgia R. Sampedro et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Tissue-Specific Patterning of Host Innate Immune Responses by Staphylococcus aureus α-Toxin
Russell E. N. Becker et al.
JOURNAL OF INNATE IMMUNITY (2014)
Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection
Arby Abtin et al.
NATURE IMMUNOLOGY (2014)
A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults
Gabriel J. Robbie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a US population: a retrospective population-based study
Gary Thomas Ray et al.
BMC INFECTIOUS DISEASES (2013)
A Serologic Correlate of Protective Immunity Against Community-Onset Staphylococcus aureus Infection
Stephanie A. Fritz et al.
CLINICAL INFECTIOUS DISEASES (2013)
Tissue penetration and antimicrobial activity of standard- and high-dose trimethoprim/sulfamethoxazole and linezolid in patients with diabetic foot infection
Gary E. Stein et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Worrisome Trend of New Multiple Mechanisms of Linezolid Resistance in Staphylococcal Clones Diffused in Italy
Floriana Campanile et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Effects of Linezolid on Suppressing In Vivo Production of Staphylococcal Toxins and Improving Survival Outcomes in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia
Binh An Diep et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Treatment Failure and Costs in Patients With Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue Infections: A South Texas Ambulatory Research Network (STARNet) Study
Matthew J. Labreche et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2013)
Local Inflammation Exacerbates the Severity of Staphylococcus aureus Skin Infection
Christopher P. Montgomery et al.
PLOS ONE (2013)
Staphylococcus aureus Alpha Toxin Suppresses Effective Innate and Adaptive Immune Responses in a Murine Dermonecrosis Model
Christine Tkaczyk et al.
PLOS ONE (2013)
Staphylococcus aureus α-Toxin: Nearly a Century of Intrigue
Bryan J. Berube et al.
TOXINS (2013)
Genetic Environment and Stability of cfr in Methicillin-Resistant Staphylococcus aureus CM05
Jeffrey B. Locke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome
Katherine S. Long et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Comparative In Vivo Efficacies of Epithelial Lining Fluid Exposures of Tedizolid, Linezolid, and Vancomycin for Methicillin-Resistant Staphylococcus aureus in a Mouse Pneumonia Model
Pamela R. Tessier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Identification of Anti-Alpha Toxin Monoclonal Antibodies That Reduce the Severity of Staphylococcus aureus Dermonecrosis and Exhibit a Correlation between Affinity and Potency
C. Tkaczyk et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Clinical Efficacy of Oral Linezolid Compared With Intravenous Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus-Complicated Skin and Soft Tissue Infections: A Retrospective, Propensity Score-Matched, Case-Control Analysis
Kamal M. F. Itani et al.
CLINICAL THERAPEUTICS (2012)
Genetic Requirement for ADAM10 in Severe Staphylococcus aureus Skin Infection
Naoko Inoshima et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Genomic Analysis of the Emergence of Vancomycin-Resistant Staphylococcus aureus
Scott D. Kobayashi et al.
MBIO (2012)
Neutrophil-derived IL-1β Is Sufficient for Abscess Formation in Immunity against Staphylococcus aureus in Mice
John S. Cho et al.
PLOS PATHOGENS (2012)
Neutrophil survival and c-kit+-progenitor proliferation in Staphylococcus aureus-infected skin wounds promote resolution
Min-Ho Kim et al.
BLOOD (2011)
Inflammation and wound healing: the role of the macrophage
Timothy J. Koh et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
Macrophages in skin injury and repair
Babak Mahdavian Delavary et al.
IMMUNOBIOLOGY (2011)
Increasing Role of Staphylococcus aureus and Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in the United States: A 10-Year Trend of Replacement and Expansion
Robertino M. Mera et al.
MICROBIAL DRUG RESISTANCE (2011)
Immunity against Staphylococcus aureus cutaneous infections
Lloyd S. Miller et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Complicated skin and soft tissue infection
Matthew S. Dryden
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice
John S. Cho et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Differential Roles of Macrophages in Diverse Phases of Skin Repair
Tina Lucas et al.
JOURNAL OF IMMUNOLOGY (2010)
Targeting of Alpha-Hemolysin by Active or Passive Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model
Adam D. Kennedy et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
COMPARISON OF THE PHARMACOKINETIC PROPERTIES OF VANCOMYCIN, LINEZOLID, TIGECYCLIN, AND DAPTOMYCIN
Kerry S. Estes et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2010)
In Vivo Activity of the Pyrrolopyrazolyl-Substituted Oxazolidinone RWJ-416457
Jamese J. Hilliard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Vaccine protection against Staphylococcus aureus pneumonia
Juliane Bubeck Wardenburg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)
William F. Dall'Acqua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Inflammatory cells during wound, repair: the good, the bad and the ugly
P Martin et al.
TRENDS IN CELL BIOLOGY (2005)
Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Increasing the affinity of a human IgG1, for the neonatal Fc receptor: Biological consequences
WF Dall'Acqua et al.
JOURNAL OF IMMUNOLOGY (2002)
Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections
DL Stevens et al.
CLINICAL INFECTIOUS DISEASES (2002)
Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus
L Mölne et al.
INFECTION AND IMMUNITY (2000)
Share Paper
